Company Search:
Advanced Search
Sponsored Links
MaxCyte Inc Company Snapshot
MaxCyte Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MaxCyte Inc with three other companies in this sector in the United Kingdom: Midatech Pharma PLC (2016 sales of £6.92 million [US$9.67 million] of which 81% was Commercial), Vernalis Plc (£12.03 million [US$16.81 million] of which 67% was Research and development), and Bioventix Plc (£5.52 million [US$7.71 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
MaxCyte Inc
  Stock Performance Chart for MaxCyte Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 249.00p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks -0.4%  
4 Weeks 3.8%   52 Weeks -13.4%  
MaxCyte Inc Key Data:
  Ticker: MXCT Country: United States
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 9,125,931
(Year Ending Jan 2017).
Employees: 32
  Currency: Pounds Sterling Market Cap: 126,777,526
  Fiscal Yr Ends: December Shares Outstanding: 50,914,669
  Share Type: Ordinary Closely Held Shares: 20,459,120
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.